BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7652764)

  • 41. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
    Kosiewicz MM; Streilein JW
    J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secondary delayed type hypersensitivity to H-2 subregion-coded alloantigens.
    Bianchi AT; Hussaarts-Odijk LM; Benner R
    Immunobiology; 1985 Sep; 170(3):192-202. PubMed ID: 3863787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
    Niederkorn JY; Streilein JW
    J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation.
    Skelsey ME; Mayhew E; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5242-51. PubMed ID: 14638723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of delayed-type hypersensitivity. VII. The role of I-J subregion gene products in the inhibition of delayed-type hypersensitivity to major histocompatibility antigens by specific suppressor T cells.
    Liew FY
    Eur J Immunol; 1981 Nov; 11(11):883-8. PubMed ID: 6173227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells.
    Okamoto S; Hara Y; Streilein JW
    Transplantation; 1995 Feb; 59(3):377-81. PubMed ID: 7871568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abrogation of anterior-chamber-induced suppression of delayed-type hypersensitivity responses by monoclonal anti-I-J antibodies.
    Niederkorn JY; Waltenbaugh C; Streilein JW
    Transplantation; 1984 Jun; 37(6):623-5. PubMed ID: 6233772
    [No Abstract]   [Full Text] [Related]  

  • 54. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.
    Skelsey ME; Mayhew E; Niederkorn JY
    Immunology; 2003 Sep; 110(1):18-29. PubMed ID: 12941137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
    Ferguson TA; Herndon JM
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eye-mediated induction of specific immune tolerance to encephalitogenic antigens.
    Farooq SM; Ashour HM
    CNS Neurosci Ther; 2013 Jul; 19(7):503-10. PubMed ID: 23522052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipopolysaccharide-induced suppression of DTH-reactivity to histocompatibility antigens. I. Kinetic aspects and specificity.
    Molendijk A; Bril H; Hussaarts-Odijk LM; van Gurp RJ; Benner R
    Immunobiology; 1988 Feb; 176(3):255-71. PubMed ID: 2966104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
    Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
    Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.